AGENUS INC Tax Withholding Paid on Stock Awards
AGENUS INC (AGEN) reported Tax Withholding Paid on Stock Awards of $527.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2020-03-16
- AGENUS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2017-12-31 was -$223.00.
- AGENUS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2017-09-30 was $0.00.
- AGENUS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2016-12-31 was $0.00.
- AGENUS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2016-09-30 was $0.00.
- AGENUS INC payment, tax withholding, share-based payment arrangement for fiscal 2017 was $527.00K, a 21.00% decline from fiscal 2016.
- AGENUS INC payment, tax withholding, share-based payment arrangement for fiscal 2016 was $667.05K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | -$223.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$223.00 derived: sum of 2 quarters · filed 2020-03-16 | $527.00K 10-K · filed 2020-03-16 | $527.22K 10-K · filed 2018-03-16 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $527.22K 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $527.22K 10-Q · filed 2018-08-09 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $667.05K 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $667.05K 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $667.05K 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |